These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 3145878

  • 1. The effect of gonadotrophin releasing hormone analogue on height prognosis in growth hormone deficiency and normal puberty.
    Stanhope R, Brook CG.
    Eur J Pediatr; 1988 Dec; 148(3):200-2. PubMed ID: 3145878
    [Abstract] [Full Text] [Related]

  • 2. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R, Gunczler P.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [Abstract] [Full Text] [Related]

  • 3. Final height in sexually precocious girls after therapy with an intranasal analogue of gonadotrophin-releasing hormone (buserelin).
    Stasiowska B, Vannelli S, Benso L.
    Horm Res; 1994 Aug; 42(3):81-5. PubMed ID: 7995616
    [Abstract] [Full Text] [Related]

  • 4. Failure to improve height prediction in short-stature pubertal adolescents by inhibiting puberty with luteinizing hormone-releasing hormone analogue.
    Lindner D, Job JC, Chaussain JL.
    Eur J Pediatr; 1993 May; 152(5):393-6. PubMed ID: 8319702
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.
    Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SD.
    J Pediatr; 1993 Aug; 123(2):215-22. PubMed ID: 8345416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [LH-RH agonist in subjects treated with growth hormone for somatotropin deficiency. Development of growth velocity and prediction of body height].
    Leheup B, Schaeffer L, Jeandel C, Pierson M.
    Pediatrie; 1992 Aug; 47(4):291-5. PubMed ID: 1329014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of manipulation of puberty on growth.
    Lee PA.
    Horm Res; 2003 Aug; 60(Suppl 1):60-7. PubMed ID: 12955020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Horm Res; 1993 Aug; 39(3-4):111-7. PubMed ID: 8262471
    [Abstract] [Full Text] [Related]

  • 18. Relationships between puberty and growth at adolescence in growth-hormone-deficient males: effect of growth hormone and of associated gonadal suppression therapy.
    Tanaka T, Yoshizawa A, Tanae A, Hibi I, Shizume K.
    Horm Res; 1990 Aug; 33 Suppl 4():102-5. PubMed ID: 2147164
    [Abstract] [Full Text] [Related]

  • 19. The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).
    Stanhope R, Adams J, Brook CG.
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):795-806. PubMed ID: 3926352
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.